Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Morilak, David A

University Of Texas Hlth Science Center
United States

Therapy-induced cognitive impairment in a rat model of prostate cancer 5R01CA285183-03 John Clifford, Ph.D.
Morin, Olivier

University Of California, San Francisco
United States

Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity 1R01CA292043-01A1 Marjorie Perloff, M.D.
Morin, Olivier

University Of California, San Francisco
United States

Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity 1R01CA292043-01A1 Marjorie Perloff, M.D.
Moscicki, Anna-Barbara

University Of California Los Angeles
United States

Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies 5R01CA281293-03 Maria Silvina Frech, Ph.D., M.S.
Moses, John Edward

Cold Spring Harbor Laboratory
United States

Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer 1UG3CA290364-01A1 Altaf Mohammed, Ph.D.
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mu, Ping

Yale University
United States

Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Mugo, Nelly Rwamba

Kenya Medical Research Institute (Kemri)
United States

KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH 3UG1CA285132-03S1 Maria Silvina Frech, Ph.D., M.S.
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

The NCI Community Oncology Research Program: The New Mexico NCORP 3UG1CA189856-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

The NCI Community Oncology Research Program: The New Mexico NCORP 3UG1CA189856-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs 3R34CA284983-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa 3R37CA306827-01S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Murenzi, Gad

Research For Development
United States

Rwanda CASCADE Clinical Trials Site for cervical cancer prevention 5UG1CA284908-03 Maria Silvina Frech, Ph.D., M.S.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials